搜索结果

Search Results for " lapatinib "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T0078	Lapatinib GSK572016,GW572016,拉帕替尼	EGFR; Ferroptosis; Autophagy	Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors
	Lapatinib (GW572016) 是一种 ErbB2 和 EGFR 的抑制剂 (IC50=9.2/10.8 nM)，具有口服活性。Lapatinib 具有抗肿瘤活性，可以用于治疗 HER2 过表达的晚期或转移性乳腺癌。
T0078L	Lapatinib ditosylate monohydrate Lapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohydrate,Lapatinib tosilate hydrate,Lapatinib tosilate,Tykerb,二甲苯磺酸拉帕替尼单水合物,Tyverb	EGFR; Ferroptosis; Autophagy	Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors
	Lapatinib ditosylate (Lapatinib tosilate) monohydrate 是一种有效的 EGFR 和 ErbB2 抑制剂，对 EGFR 和 ErbB2的 IC50值分别为 10.8 和 9.2 nM。它用于治疗晚期乳腺癌和其他实体瘤。
T6235	Lapatinib Ditosylate Lapatinib (GW-572016) Ditosylate,二甲苯磺酸拉帕替尼,二对甲苯磺酸拉帕替尼,GW-572016 ditosylate,Tykerb ditosylate	EGFR; Ferroptosis; Autophagy	Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors
	Lapatinib Ditosylate (Tykerb ditosylate) 是一种有效的 EGFR 和 ErbB2 抑制剂，对 EGFR 和 ErbB2的 IC50值分别为 10.8 和 9.2 nM。它用于治疗晚期乳腺癌和其他实体瘤。
T0077	Dantrolene sodium Lapatinib ditosylate monohydrate,丹曲林钠,Dantrolene sodium salt	Others; Calcium Channel	Membrane transporter/Ion channel; Metabolism; Others
	Dantrolene sodium (Lapatinib ditosylate monohydrate) salt 是一种骨骼肌松弛药，是一种钙通道蛋白抑制剂，可抑制钙离子从肌浆释放。
T72577	Lapatinib tosylate GW2016 tosylate,GW572016 tosylate,GW572016 tosylate ; GW2016 tosylate
	Lapatinib (GW572016) tosylate 是一种有效的，具有口服活性的 ErbB-2和 EGFR 酪氨酸激酶结构域的抑制剂，对纯化的EGFR 和ErbB-2的IC50值分别为 10.2 和 9.8 nM。
T6092	Sapitinib 沙普替尼,AZD-8931	EGFR	Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
	Sapitinib (AZD-8931) 是可逆的 ATP 竞争型 EGFR 抑制剂，对 EGFR、ErbB2 和 ErbB3的IC50值分别为4、3 和 4 nM。
T36244	SJF 1521
	Selective EGFR Degrader. Comprises the EGFR inhibitor lapatinib (Cat. No. 6811) joined by a linker to a von Hippel-Lindau (VHL) recruiting ligand. Exhibits selectivity for EGFR, including mutant forms, over HER2. Induces degradation of EGFR in OVCAR8 cells.
T36245	SJF 1528
	Potent EGFR Degrader (DC50 values are 39.2 nM for wild-type EGFR in OVCAR8 cells and 736 nM for Exon20Ins mutated EGFR in HeLa cells). Also degrades HER2. Comprises the EGFR inhibitor lapatinib (Cat. No. 6811) joined by a linker to a von Hippel-Lindau (VHL) recruiting ligand. Inhibits proliferation of HER2-driven breast cancer cell lines (IC50 = 102 nM for SKBr3 cells).